<?xml version="1.0" encoding="UTF-8"?>
<collection>
<dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:invenio="http://invenio-software.org/elements/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:identifier>doi:10.1136/postgradmedj-2020-137491</dc:identifier><dc:language>eng</dc:language><dc:creator>García-Gil, M. F.</dc:creator><dc:creator>Lezcano Biosca, V.</dc:creator><dc:creator>García García, M.</dc:creator><dc:creator>Monte Serrano, J.</dc:creator><dc:creator>Aldea Manrique, B.</dc:creator><dc:title>Bullous pemphigoid and dipeptidyl peptidase-4 inhibitors: The importance of the pharmacotherapeutic history</dc:title><dc:identifier>ART-2021-122394</dc:identifier><dc:description>A 97-year-old man with a history of type II diabetes mellitus was treated with oral antidiabetic agents. He went to the emergency department after the appearance of blister-like itchy lesions on the abdomen and extremities since 2 months. The examination revealed eczematous lesions on the back, abdomen and extremities along with tense blisters on an erythematous base and serous content...</dc:description><dc:date>2021</dc:date><dc:source>http://zaguan.unizar.es/record/109064</dc:source><dc:doi>10.1136/postgradmedj-2020-137491</dc:doi><dc:identifier>http://zaguan.unizar.es/record/109064</dc:identifier><dc:identifier>oai:zaguan.unizar.es:109064</dc:identifier><dc:identifier.citation>POSTGRADUATE MEDICAL JOURNAL 97, 1143 (2021), 51-52</dc:identifier.citation><dc:rights>All rights reserved</dc:rights><dc:rights>http://www.europeana.eu/rights/rr-f/</dc:rights><dc:rights>info:eu-repo/semantics/openAccess</dc:rights></dc:dc>

</collection>